<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report(Date of earliest event reported): December 8, 1995
BARRINGER LABORATORIES, INC.
(Exact name of registrant as specified in its Charter)
Delaware
(State or other jurisdiction of incorporation or organization)
0-8241 84-0951626
(Commission file number) I.R.S. Employer
(Identification No.)
15000 West 6th Avenue, Suite 300 80401
Golden, Colorado (Zip Code)
(Address of principal
executive offices)
Registrant's telephone number, including area code:
(303) 277-1687
<PAGE>
ITEM 5. OTHER EVENTS
Effective December 13, 1995 under an agreement dated December 8, 1995,
Barringer Laboratories, Inc. (the "Company") purchased from Barringer
Technologies, Inc. ("BTI") 647,238 shares of the Company's common stock which
were owned by BTI for $809,048, which consisted of a cash payment of $300,000
and cancellation of intercompany obligations in the amount of $509,048.
Additionally, 88,260 shares of the Company's Common Stock owned by BTI were
placed in an escrow account, which will be returned to BTI if certain
earnings are achieved by the Company in 1996. BTI has agreed not to transfer
its remaining 26% interest in BLI until January 2, 1997, subject to certain
conditions, and has agreed to grant BLI a right of first refusal with respect
to such shares until January 2, 1997, subject to certain conditions.
Intercompany Agreement between the Company and BTI was terminated on December
13, 1995. BTI agreed to terminate all voting trusts, proxy arrangements, and
all other arrangements and agreements of any kind or nature to which it is a
party under which it is authorized to vote shares of the Company. BTI
further agreed not to enter into any future voting trusts, proxy agreements,
and any other agreements relating to shares of the Company for the next
twenty-four (24) months.
The following itemizes the purchase transaction with BTI.
<TABLE>
<S> <C>
Note Due from BTI on 11/30/95 $451,945
Accounts Receivable due BTI on 12/1/95 57,103
Cash Payment to BTI 300,000
--------
Total Transaction $809,048
--------
--------
</TABLE>
Additionally, the Company incurred approximately $37,000 in professional fees
relating to this stock transaction. The common stock purchased by the
Company and total transaction value of approximately $846,048 will be
recorded as Treasury stock.
-2-
<PAGE>
ITEM 5. OTHER EVENTS (CONTINUED)
The following table lists the Company's outstanding common stock and BTI
percentage ownership in the Company pre-transaction and post-transaction.
<TABLE>
<CAPTION>
Pre Post
Transaction Transaction
----------- -----------
<S> <C> <C>
Number of Shares of
Company's Common Stock
Outstanding as of
December 13, 1995 2,299,254 1,652,016
Number of Outstanding
Shares of Common Stock
Owned by BTI 1,079,713 432,475
BTI Percent Ownership of
Company's Common Stock 46.96% 26.17%
----------- -----------
----------- -----------
</TABLE>
The following is an unaudited Pro Forma Consolidated Balance Sheet
as of November 30, 1995 reflecting this stock transaction.
-3-
<PAGE>
BARRINGER LABORATORIES, INC.
UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET
AS OF NOVEMBER 30, 1995
<TABLE>
<CAPTION>
11/30/95
Balance 11/30/95
Sheet Pro Forma
---------- ----------
<S> <C> <C>
ASSETS
Current Assets
Cash $ 524,000 $ 224,000
Trade Receivables, Net 874,000 874,000
Due From Affiliate - BTI 57,000 -
Prepaid Expenses and Other 66,000 48,000
---------- ----------
Total Current Assets 1,521,000 1,146,000
Property and Equipment
Gross Property and Equipment 3,050,000 3,050,000
Less Accumulated Depreciation 2,429,000 2,429,000
---------- ----------
Net Property and Equipment 621,000 621,000
Note Receivable from Affiliate - BTI 452,000 -
Other Assets 53,000 53,000
---------- ----------
Total Assets $2,647,000 $1,820,000
---------- ----------
---------- ----------
Liabilities and Shareholders' Equity
Liabilities
Current Liabilities
Line of Credit 32,000 32,000
Trade Accounts Payables 234,000 234,000
Accrued Liabilities 334,000 353,000
Current Maturities of Ltd. 157,000 157,000
---------- ----------
Total Current Liabilities 757,000 776,000
Long-term Debt Less Current Maturities 44,000 44,000
---------- ----------
Total Liabilities 801,000 820,000
Shareholders' Equity
Common Stock 23,000 23,000
Additional Paid-in Capital 3,278,000 3,278,000
Treasury Stock at Cost
(647,238 Shares) - (846,000)
Deficit (1,434,000) (1,434,000)
Translation Adjustment (21,000) (21,000)
---------- ----------
Total Shareholders' Equity 1,846,000 1,000,000
Total Liabilities and
Shareholders' Equity $2,647,000 $1,820,000
---------- ----------
---------- ----------
</TABLE>
-4-
<PAGE>
ITEM 5. OTHER EVENTS (CONTINUED)
(a) Exhibit
10.27 Stock Purchase Agreement between Barringer
Laboratories, Inc. and Barringer Technologies,
Inc. dated December 8, 1995.
-5-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
BARRINGER LABORATORIES, INC.
/s/ Charles E. Ramsay
---------------------------------------
Charles E. Ramsay
Chief Financial Officer
December 21, 1995
-6-
<PAGE>
STOCK PURCHASE AGREEMENT
This Agreement is made and entered into 8th day of December, 1995, by and
among Barringer Laboratories, Inc., a Delaware corporation ("Buyer"), and
Barringer Technologies, Inc., a Delaware corporation, ("Seller"). Buyer and
Seller may be referred to herein collectively as "Parties."
WHEREAS, Seller owns one million seventy-nine thousand seven hundred
thirteen shares of the issued and outstanding shares of Barringer Laboratories,
Inc. common stock, free and clear of all liens, encumbrances and adverse claims
other than a security interest granted in favor of Buyer pursuant to the terms
of that certain Agreement executed by and between the Parties on the 1st day of
May, 1991 (the "Intercompany Agreement"),
WHEREAS, Seller is the major shareholder of Buyer and exercises voting
control of Buyer through voting trusts, proxy arrangements or otherwise;
WHEREAS, Seller desires to sell, and Buyer desires to purchase, six hundred
forty-seven thousand two hundred thirty-eight (647,238) shares of the issued and
outstanding shares of Barringer Laboratories, Inc. common stock which it owns
and to reach agreements upon the other matters set forth below, for the
consideration and upon the terms and subject to the conditions hereinafter set
forth.
NOW, THEREFORE, in consideration of these Recitals and the provisions and
the respective agreements hereinafter set forth, the Parties hereto hereby agree
as follows:
1.Purchase and Sale of Stock.
1.1 AGREEMENT TO PURCHASE AND SELL. Upon the terms and subject
to the conditions set forth in this Agreement and upon the representations and
warranties made herein by each of the Parties to the other, on the Closing Date
(as such term is hereinafter defined), Seller shall sell, grant, convey, assign,
transfer and deliver to Buyer, and Buyer shall purchase and acquire from Seiler,
six hundred forty-seven thousand two hundred thirty-eight (647,238) shares of
the issued and outstanding shares of Barringer Laboratories, Inc. common stock
which Seller owns (the "Shares"). The Shares will be delivered to Buyer at
Closing (as such term is hereinafter defined) free and clear of all liens,
encumbrances and adverse claims.
1.2 PURCHASE PRICE. Upon the terms and subject to the
conditions set forth in this Agreement, in reliance upon the representations,
warranties, covenants and agreements of Seiler contained herein, and in exchange
for the Shares, Buyer agrees to pay to Seller the sum of eight hundred nine
thousand forty-eight dollars ($809,048) (the "Purchase Price").
1.3 PAYMENT OF PURCHASE PRICE. The Purchase Price shall be
payable at Closing as follows: (i) by delivery of three hundred thousand dollars
($300,000) in
<PAGE>
immediately available funds to Seller in such bank accounts as Seller shall
designate in writing to Buyer at least 24 hours prior to the Closing Date; (ii)
by cancellation at Closing of unpaid principal owed by Seller to Buyer under the
Intercompany Agreement in the amount of four hundred fifty one thousand nine
hundred forty five dollars ($451,945); and (iii) by cancellation at Closing of
accounts receivable due from Seller to Buyer in the amount of fifty-seven
thousand one hundred three dollars ($57,103).
1.4 Closing. The closing of the purchase and sale of the Shares
provided herein (the "Closing") will be at the office of Rumier Davies, P.C. at
10:00 a.m., local time, on December 13, 1995, or at such other place or at such
other date and time as Seller and Buyer may mutually agree. Such date and time
of Closing is herein referred to as the "Closing Date."
2. Representations and Warranties of Seller.
Seller represents and warrants, which representations and warranties
shall survive the Closing, to Buyer as follows:
2.1 EXISTENCE, GOOD STANDING, CORPORATE AUTHORITY, AND
COMPLIANCE WITH LAW. Seller is a corporation duly incorporated, validly
existing and in good standing under the laws of its jurisdiction of
incorporation. Seller has all requisite corporate power and authority to own
and sell the Shares pursuant to the terms and conditions of this Agreement.
Seller is not (i) in default with respect to any order of any court,
governmental authority or arbitration board or tribunal to which it is a party
or is subject which relates to the transfer of the Shares and or Sellers
execution and performance of this Agreement, and (ii) in violation of any laws,
ordinances, governmental rules or regulations to which it is subject and which
relates to the transfer of the Shares and\or Seller's execution and performance
of this Agreement.
2.2 VALIDITY AND EFFECT OF AGREEMENTS. This Agreement
constitutes, and all agreements and documents contemplated hereby when
executed and delivered pursuant hereto for value received will constitute, the
valid and legally binding obligations of Seller enforceable in accordance with
their terms, except that enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, fraudulent transfer, moratorium or other similar
laws of general application now or hereafter in effect relating to the
enforcement of creditors' rights generally and except that the remedies of
specific performance, injunction and other forms of equitable relief are
subject to certain tests of equity jurisdiction, equitable defenses and the
discretion of the court before which any proceeding therefor may be brought.
The execution and delivery of this Agreement does not and the consummation of
the transactions contemplated hereby will not (i) require the consent of any
third party, or (ii) result in the breach of any term or provision of, or
constitute a default under, or result in the acceleration of or entitle any
party to accelerate (whether after the giving of notice or the lapse of time
or both) any obligation under, or result in the creation
2
<PAGE>
or imposition of any lien, charge, pledge, security interest or other
encumbrance upon all or any part of the Shares pursuant to any provision of, any
order, judgment, arbitration award, injunction, decree, indenture, mortgage,
lease, license, lien, or other agreement or instrument to which Seller is a
party or by which it is bound, or violate or conflict with any provision of the
by-laws or articles/certificate of incorporation of Seller as amended to the
date of this Agreement, except which have been waived in writing prior to the
date hereof and copies of which have been supplied to Buyer prior to closing.
2.3 SHARES. Seller owns one million seventy-nine thousand seven
hundred thirteen shares of the fully paid and nonassessable issued and
outstanding shares of Barringer Laboratories, Inc. common stock free and clear
of all liens, encumbrances and adverse claims other than a security interest
granted in favor of Buyer pursuant to the terms of the Intercompany Agreement.
Except for rights granted pursuant to this Agreement, there are no outstanding
rights, options, contracts, agreements or commitments giving anyone any the
right to acquire the Shares. The Shares are subject to no restrictions with
respect to transferability to Buyer in accordance with the terms of this
Agreement. Upon transfer of the Shares by Seller, Buyer will, as a result,
receive good and marketable title to all of the Shares, free and clear of all
security interests, liens, encumbrances, charges, assessments, restrictions and
adverse claims, except those granted to Buyer and, except as otherwise provided
herein, those created under applicable securities laws.
2.4 FINANCIAL STATEMENTS. Buyer has furnished to Seller its (i)
audited balance sheet and notes thereto as of the end of the last fiscal year
(the "Audited Balance Sheet"), (ii) its audited statement of operations for the
last fiscal year, (iii) its unaudited balance sheets and notes thereto for each
month since its fiscal year end, and (iv) its unaudited statement of operations
for each month since its fiscal year end.
2.5 TAXES. The Seller (i) has duly and timely filed or caused
to be filed all federal, state, local and foreign tax returns (including,
without limitation, consolidated and/or combined tax returns) required to be
filed by it prior to the date of this Agreement with respect to which the Seller
is liable or otherwise in any way subject, and (ii) has paid or fully accrued
for all taxes shown to be due and payable on such returns (which taxes are all
the taxes due and payable under the laws and regulations pursuant to which such
returns were filed). No deficiency in payment of taxes for any period has been
asserted by any taxing body and remains unsettled at the date of this Agreement.
2.6 LITIGATION. There are no actions, suits or proceedings with
respect to the Seller involving claims by or against Seller which are pending or
threatened against Seller, at law or in equity, or before or by any federal,
state, municipal or other governmental department, commission, board, bureau,
agency or instrumentality which affect the Shares or the Seller's ability to
enter into or perform its obligations hereunder. No basis for any action, suit
or proceeding exists, and there are no orders, judgments, injunctions or
3
<PAGE>
decrees of any court or governmental agency with respect to which Seller has
been named or to which Seller is a party, which apply to or restrict Seller's
performance of this Agreement and the transaction contemplated hereunder.
2.7 NO BROKERS. Seller has not entered into any contract,
arrangement or understanding with any person or firm which may result in the
obligation of Buyer to pay any finders fees, brokerage or agent's commissions or
other like payments in connection with the negotiations leading to this
Agreement or the consummation of the transactions contemplated hereby, and
Seller is not aware of any claim or basis for any claim for payment of any
finders fees, brokerage or agents commissions or other like payments in
connection with the negotiations leading to this Agreement or the consummation
of the transactions contemplated hereby.
2.8 EVALUATION OF TRANSACTION. Seller has knowledge and
experience in financial and business matters and is capable of evaluating the
risk and merits of the transaction contemplated by this Agreement. Seller has
consulted with counsel and its other advisors, to the extent deemed necessary,
as to all matters covered by this Agreement and has not relied upon Buyer to any
extent in reaching its decision to sell the Shares pursuant to this Agreement.
In reaching its decision to sell the Shares, Seller has investigated and is
familiar with the affairs, financial condition and prospects of Buyer, and has
been given sufficient access to and has acquired sufficient information about
Buyer to reach an informed and knowledgeable decision to sell the Shares.
2.9 NO MISREPRESENTATION OR OMISSION. No representation or
warranty by Seller in this Article 2 or in any other Article or Section of this
Agreement, or in any certificate or other document furnished or, if to be
furnished by Seller pursuant hereto upon delivery, contains or will contain any
untrue statement of a material fact or omits or will omit to state a material
fact necessary to make the statements contained therein not misleading or will
omit to state a material fact.
3. REPRESENTATIONS AND WARRANTIES OF BUYER.
Buyer represents and warrants, which representations and warranties shall
survive the Closing, to Seller as follows:
3.1 EXISTENCE, GOOD STANDING, CORPORATE AUTHORITY. COMPLIANCE
WITH LAW, VALIDITY AND EFFECT OF AGREEMENTS. Buyer represents and warrants to
Seller that Buyer is a corporation duly incorporated, validly existing and in
good standing under the laws of its jurisdiction of incorporation, that the
execution and delivery of this Agreement and all agreements and documents
contemplated hereby by Buyer, and the consummation by it of the transactions
contemplated hereby, have been duly authorized by the disinterested members of
the Board of Directors of the Buyer. This Agreement constitutes, and all
agreements and documents contemplated hereby when executed and delivered
pursuant
4
<PAGE>
hereto for value received will constitute, the valid and legally binding
obligations of Buyer enforceable in accordance with their terms, except that
enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, fraudulent transfer, moratorium or other similar laws of general
application now or hereafter in effect relating to the enforcement of creditors'
rights generally and except that the remedies of specific performance,
injunction and other forms of equitable relief are subject to certain tests of
equity jurisdiction, equitable defenses and the discretion of the court before
which any proceeding therefor may be brought. The execution and delivery of
this Agreement does not and the consummation of the transactions contemplated
hereby will not require the consent of any third party (except as set forth in
Section 5.1 of this Agreement), and (ii) violate or conflict with any provision
of the by-laws or certificate of incorporation of Buyer as amended to the date
of this Agreement
3.2 LITIGATION. There are no actions, suits or proceedings with
respect to the Buyer involving claims by or against Buyer which are pending or
threatened against Buyer, at law or in equity, or before or by any federal,
state, municipal or other governmental department, commission, board, bureau,
agency or instrumentality which affect the Shares or the Buyers ability to enter
into or perform its obligations hereunder. There are no orders, judgments,
injunctions or decrees of any court or governmental agency with respect to
which Buyer has been named or to which Buyer is a party, which apply to or
restrict Buyers performance of this Agreement and the transaction contemplated
hereunder.
3.3 NO BROKERS. Buyer has not entered into any contract,
arrangement or understanding with any person or firm which may result in the
obligation of Buyer to pay any finder's fees, brokerage or agents commissions or
other like payments in connection with the negotiations leading to this
Agreement or the consummation of the transactions contemplated hereby, and Buyer
is not aware of any claim or basis for any claim for payment of any finders
fees, brokerage or agent's commissions or other like payments in connection with
the negotiations leading to this Agreement or the consummation of the
transactions contemplated hereby.
3.4 NO MISREPRESENTATION OR OMISSION. No representation or
warranty by Buyer in this Article 3 or in any other Article or Section of this
Agreement, or in any certificate or other document finished or, if to be
finished by Buyer pursuant hereto upon delivery, contains or will contain any
untrue statement of a material fact or omits or will omit to state a material
fact necessary to make the statements contained therein not misleading or will
omit to state a material fact.
5
<PAGE>
4. Other Covenants and Agreements.
4.1 TERMINATION OF INTERCOMPANY AGREEMENT. The Parties
acknowledge that at Closing, all outstanding monies due and owing under the
Intercompany Agreement shall have been paid in full. Consequently, effective
on the consummation of the transaction contemplated by this Agreement at
Closing the Intercompany Agreement and all Addenda thereto shall be
terminated and the parties shall have no further rights, duties or
obligations thereunder, except for the terms of paragraph 3 of the
Intercompany Agreement. The Parties agree that Buyer shall retain and
continue to hold a perfected security interest in eighty eight thousand two
hundred sixty (88,260) shares of the Barringer Laboratories, Inc. common
stock which Seller will continue to own after Closing, pursuant to the terms
and conditions of Paragraph 3 of the Intercompany Agreement and the documents
referred to therein, as collateral to secure any obligation of Seller which
might arise under Section 4.8.2 hereunder. Buyer shall at Closing return all
shares of Barringer Laboratories, Inc. stock not purchased or held as
collateral pursuant to the terms of this Agreement, which it currently holds.
All shares returned to Seller shall be transferred free and clear of all
liens, encumbrances and adverse claims except those granted by Seller and,
except as otherwise provided herein, those created under applicable
securities laws.
4.2 INSURANCE MATTERS.
4.2.1 HEALTH INSURANCE BENEFITS. To the extent permitted by its
health insurance carrier, Buyer shall allow Seller to insure Sellers employees
under Buyers group health insurance policy until the renewal date of the policy,
upon the terms and conditions set forth in this Agreement. Each month Buyer
shall invoice Seller for the estimated cost of providing insurance to Sellers
employees during the following month. Seller shall remit such amount to Buyer
within thirty days of the date of the invoice. If Seller fails to remit the
invoiced amount within such thirty day period, Buyer shall have no further
obligation to make any payments respecting or provide coverage to or for the
benefit of Sellers employees.
4.2.2 GENERAL LIABILITY AND D&O COVERAGE. To the extent
permitted by its general liability and D&O insurance carriers, Buyer shall be
allowed to be an additional insured on Sellers property, casualty and D&O
insurance policies through the end of each such policy period. Each Party shall
pay its share of the premiums directly to the insurer on a timely basis.
4.3 TERMINATION VOTING ARRANGEMENTS. Seller agrees to terminate
all voting trusts, proxy arrangements and all other arrangements and agreements
of any kind or nature to which it is a party under which it or any other person
or entity is authorized to vote shares of Barringer Laboratories, Inc. stock,
effective as of the Closing Date. Further, for a period of twenty-four months
following the Closing Date, Seller agrees that it will not enter into any voting
trusts, proxy arrangements or any other arrangement or agreement of any kind or
nature other than as required by any customary pledge or hypothecation
6
<PAGE>
agreements to which Seller is a party with any institutional lender under which
it or any other person or entity is authorized to vote shares of Barringer
Laboratories, Inc. stock, nor will it, during such period, vote any shares of
Barringer Laboratories, Inc. stock which it does not own.
4.4 RESTRICTION ON TRANSFERABILITY. Until January 2, 1997,
Seller agrees that it shall not, nor shall it have any right to, sell, assign,
transfer or otherwise dispose of any shares of Barringer Laboratories, Inc.
stock which Seller owns, without the prior written consent of Buyer, which Buyer
may grant or deny in its sale and absolute discretion. Notwithstanding the
foregoing sentence, Seller shall have the right to encumber such shares of
Barringer Laboratories, Inc. stock owned by Seller, by often agreement with any
institutional lender and, transfer title to such shares upon foreclosure of such
shares held as collateral by any such institutional lender; provided, however,
Buyer shall be given the right of first refusal for a period of 45 days
following receipt of foreclosure notice by such lender forwarded to Buyer from
Seller, with a price per share to be determined between the institutional lender
and Buyer which price per share shall not exceed $1.25. Seller shall promptly
transmit any such notice of foreclosure to Buyer. If this right of first
refusal is not exercised by often notice from Buyer to Seller, it shall expire
upon the end of said 45 day period. Nothing under this Section shall prevent
the Seller from participating with any other shareholder of Barringer
Laboratories, Inc. in the sale of fifty percent (50%) (not including shares
owned by Seller) or more of the issued and outstanding shares of Barringer
Laboratories, Inc. to any purchaser. Any sale, assignment, transfer or other
disposition of shares of Buyer owned by Seller in contravention of the terms of
this Agreement shall be null and void.
4.5 RIGHT OF FIRST REFUSAL. Until January 2, 1997, if Seller
receives a bona fide offer for the purchase of all or any part of the shares
of Barringer Laboratories, Inc. stock which it owns and if it is desirous of
selling said shares, Seller shall first offer said shares for sale to Buyer,
by letter addressed to Buyers President at its principal place of business, on
the same terms and price as the bona fide offer. Said offer shall remain open
for a period of 30 days following its receipt by Buyer. Buyer shall accept
this offer by giving written notice to Seller within the time provided. If not
so accepted, the offer shall terminate upon expiration of said 30-day period.
4.6 TERMINATION OF RESTRICTION ON TRANSFERABILITY AND RIGHT OF
FIRST REFUSAL. Section 4.4 and 4.5 above shall not apply to restrict Seller's
transferability of any shares of Barringer Laboratories, Inc. stock upon the
first to occur of (i) the closing with respect to the sale, within any twelve
month period after the date of this Agreement, of a number of the issued and
outstanding shares of Barringer Laboratories, Inc. which would be necessary to
give any one person or entity ownership of fifty percent (50%) or more of issued
and outstanding shares of Barringer Laboratories, Inc., or (ii) the change of
more than 3 members of the Board of Directors of Barringer Laboratories, Inc.,
other than a
7
<PAGE>
change occasioned by the resignation of any one or more board members, during
any twelve month period after the date of this Agreement.
4.7 RESTRICTIVE LEGEND. To effectuate the intent of the Parties
set forth in Sections 4.4 and 4.5 above, the Parties agree that the stock
certificates evidencing Sellers shares of Buyer's stock will be endorsed as
follows:
"The sale or transfer of this certificate is subject to the
restrictions on transferability set forth in the Stock Purchase
Agreement dated December 8, 1995, a copy of which is on file with the
Secretary of the Corporation."
4.8 INDEMNIFICATION BY SELLER.
4.8.1 Seller agrees to indemnify and hold Buyer harmless against,
and will reimburse Buyer on demand for, any payment, loss, cost or expense
(including reasonable attorney's fees and reasonable costs of investigation
incurred in defending against such payment, loss, cost or expense or claim
therefor) made or incurred by or asserted against Buyer at any time up to the
third anniversary after the Closing Date in respect of:
(a) any omission, misrepresentation, breach of warranty, or
nonfulfillment or breach of any term, provision, covenant or
agreement on the part of Seller contained in this Agreement, or
from any misrepresentation in, or omission from, any certificate
or other instrument furnished or to be furnished to Buyer
pursuant to this Agreement; and
(b) the failure of the Seller to have and deliver good and
marketable title to the Shares.
4.8.2 On or before Closing Buyer will use its best efforts to
obtain a fairness opinion or other document pursuant to Section 5.1.2 which will
opine or state, in part, that the per share value of common stock of Buyer is at
least one dollar and ten cents ($1.10) but would be equal to or greater than the
per share purchase price which the Buyer is paying hereunder to acquire the
Shares and that the purchase of Sellers shares is fair, from a financial point
of view, to Buyer, if Buyer's income before income taxes for calendar year 1996
as reported in the Consolidated Statements of Operations of Buyer prepared in
accordance with Generally Accepted Accounting Principles were to be at least one
hundred thirteen percent (113%) of Buyers said income before income taxes for
calendar year 1995 (the "Target Earnings"). If Buyers such income before taxes
for calendar year 1996 (the "Actual Earnings") is less than the Target Earnings,
Seller agrees to indemnify and hold Buyer harmless by transferring to Buyer a
number of the Barringer Laboratories, Inc. shares as to which Buyer holds a
security interest, determined by operation of this Section. If Actual Earnings
are greater than Target Earnings, all 88,260 shares are returned to Seller,
otherwise Seller's obligation to indemnify and hold Buyer harmless shall
8
<PAGE>
be satisfied by transferring to Buyer the number of shares equal to eighty-eight
thousand two hundred sixty (88,260) times (ii) a fraction, the numerator of
which is the positive difference between (y) Target Earnings and (z) Actual
Earnings and the denominator of which is the difference between (y) Target
Earnings and (z) Buyer's income before income taxes for calendar year 1995 as
determined in accordance with GAAP (the "1995 Earnings"). Notwithstanding the
preceding sentence, if 1995 Earnings exceed Actual Earnings, then Sellers
obligation to indemnify and hold Buyer harmless shall be satisfied by
transferring to Buyer all eighty eight thousand two hundred s@ (88,260) shares.
All of the Barringer Laboratories, Inc. shares to be transferred to Buyer and\or
Seller under this Section shall be delivered to the appropriate party promptly
after the issuance of Buyers Consolidated Financial Statements for the 1996
calendar year.
4.9 INDEMNIFICATION BY BUYER. Buyer agrees to indemnify and
hold Seller harmless against, and will reimburse Seller on demand for, any
payment, loss, cost or expense (including reasonable attorney's fees and
reasonable costs of investigation incurred in defending against such payment,
loss, cost or expense or claim therefor) made or incurred by or asserted
against Seller at any time up to the third anniversary after the Closing Date
in respect of any omission, misrepresentation, breach of warranty, or
nonfulfillment of any term, provision, covenant or agreement on the part of
Buyer contained in this Agreement, or from any misrepresentation in, or
omission from, any certificate or other instrument furnished or to be
furnished to Seller pursuant to this Agreement.
4.10 TAXES AND EXPENSES.
4.10.1 Except as other wise specifically provided for in this
Agreement, Seller shall be responsible for and shall pay all costs, liabilities,
taxes and other obligations incurred by Seller in connection with the
performance of and compliance with all transactions, agreements and conditions
contained in this Agreement to be performed or complied with by Seller,
including legal and accounting fees.
4.10.2 Except as otherwise specifically provided for in this
Agreement, Buyer will pay all costs, liabilities, taxes and other obligations
incurred by Buyer in connection with the performance of and compliance with all
transactions, agreements and conditions contained in this Agreement to be
performed or complied with by Buyer, including legal and accounting fees.
5. Conditions of Closing.
5.1 BUYER'S CONDITIONS OF CLOSING. The obligation of Buyer to
purchase and pay for the Shares shall be subject to and conditioned upon the
satisfaction at the Closing of each of the following conditions:
9
<PAGE>
5.1.1 All representations and warranties of Seller contained in
this Agreement shall be true and correct in the aggregate in all material
respects at and as of the Closing Date, Seller shall have performed in all
material respects all agreements and covenants and satisfied all conditions on
its part to be performed or satisfied by the Closing Date pursuant to the terms
of this Agreement, and Buyer shall have received a certificate of the Seller
dated the Closing Date to such effect, unless such conditions shall have been
waived by Buyer.
5.1.2 Buyer shall have received a "fairness opinion," or other
documents in form and substance satisfactory to Buyer and to the disinterested
members of its Board of Directors, which opines or states that the per share
value of Buyer is equal to or greater than the per share purchase price which
the Buyer is paying hereunder to acquire the Shares and that the purchase of
Sellers shares is fair from a financial point of view, to Buyer.
5.1.3 Seller shall have delivered to Buyer a Certificate of its
Secretary certifying as of a date reasonably close to the Closing Date that the
Seller as of such date is in good standing and authorized to transact business
as a domestic corporation in its state of incorporation.
5.1.4 Seller shall have delivered to Buyer a Certificate of its
corporate Secretary certifying:
(a) Resolutions of its Board of Director authorizing execution of
this Agreement and the execution, performance and delivery of all
agreements, documents and transactions contemplated hereby; and
(b) The incumbency of its officers executing this Agreement and
all agreements and documents contemplated hereby.
5.1.5 Seller shall have delivered to Buyer certificates and
other instruments representing all Shares, duly endorsed for transfer or
accompanied by appropriate stock powers (in either case executed in blank or in
favor of Buyer), together with all other documents necessary or appropriate to
validly transfer the Shares to Buyer free and clear of all security interests,
liens, encumbrances and adverse claims.
5.1.6 Seller shall have delivered to Buyer copies of the
termination documents for all voting trusts, proxy arrangements and all other
arrangements and agreements of any kind or nature to which it is a party under
which it or any other person or entity is authorized to vote shares of Buyer's
stock, effective as of the Closing Date.
10
<PAGE>
5.1.7 The approval and all consents from third parties and
governmental agencies required to consummate the transactions contemplated
hereby shall have been obtained.
5.1.8 No suit, action, investigation, inquiry or other
proceeding by any governmental body or other person or legal or administrative
proceeding shall have been instituted or threatened which questions the validity
or legality of the transactions contemplated hereby.
5.1.9 Seller shall have delivered to Buyer the waivers referred
to in Section 2.2 above, which shall be in form and substance satisfactory to
Buyer.
5.1.10 As of the Closing, there shall be no effective injunction,
with, preliminary restraining order or any order of any nature issued by a court
of competent jurisdiction directing that the transactions provided for herein or
any of them not be consummated as so provided or imposing any conditions on the
consummation of the transactions contemplated hereby, which is unduly burdensome
on Buyer.
5.2 SELLER'S CONDITIONS OF CLOSING. The obligation of Seller
to sell the Shares shall be subject to and conditioned upon the satisfaction
at the Closing of each of the following conditions:
5.2.1 All representations and warranties of Buyer contained in
this Agreement shall be true and correct in the aggregate in all material
respects at and as of the Closing Date and Buyer shall have performed in all
material respects all agreements and covenants and satisfied all conditions on
its part to the performed or satisfied by the Closing Date pursuant to the terms
of this Agreement, and Seller shall have received a certificate of Buyer dated
the Closing Date to such effect.
5.2.2 Buyer shall have effected payment of the cash portion of
the Purchase Price in accordance with the prior written instructions of Seller.
5.2.3 Buyer shall have executed such documents as are necessary
to release Buyer of all obligations under the Intercompany Agreement and the
account receivable, to the extent described above.
5.2.4 Buyer shall have delivered to Seller a Certificate of its
corporate Secretary certifying:
(a) Resolutions of its Board of Directors, in accordance with
Delaware law, including a resolution of the disinterested
directors, authorizing execution of this Agreement and the
execution, performance and delivery of all agreements, documents
and transactions contemplated hereby; and
11
<PAGE>
(b) The incumbency of its officers executing this Agreement and
all agreements and documents contemplated hereby.
5.2.5 The approval and all consents from third parties and
governmental agencies required to consummate the transactions contemplated
hereby shall have been obtained, copies of which have been delivered to Seller.
5.2.6 No suit, action, investigation, inquiry or other proceeding
by any governmental body or other person or legal or administrative proceeding
shall have been instituted or threatened which questions the validity or
legality of the transactions contemplated hereby.
5.2.7 As of the Closing, there shall be no effective injunction,
with, preliminary restraining order or any order of any nature issued by a court
of competent jurisdiction directing that the transactions provided for herein or
any of them not be consummated as so provided or imposing any conditions on the
consummation of the transactions contemplated hereby, which is unduly burdensome
on Seller.
6. Termination and Abandonment.
6.1 METHODS OF TERMINATION. The transactions contemplated
herein may be terminated and/or abandoned at any time before or after approval
thereof by Seller and Buyer, but not later than the Closing:
(i) By mutual consent of Buyer and Seller; or
(ii) By Buyer after December 13, 1995, if any of
the conditions provided for in Section 5.1 hereof
shall not have been met or waived in writing by Buyer
prior to such date; or
(iii) By Seller after December 13, 1995, if any of the
conditions provided for in Section 5.2 hereof shall not have
been met or waived in writing by Seller prior to such date.
6.2 PROCEDURE UPON TERMINATION. In the event of termination
and/or abandonment by Buyer or Seller, or both, pursuant to Section 6.1 hereof,
written notice thereof shall forthwith be given to the other party and the
transactions contemplated by this Agreement shall be terminated and/or
abandoned, without further action by Buyer or Seller. If the transactions
contemplated by this Agreement are terminated and/or abandoned as provided
herein:
12
<PAGE>
(i) Each Party will redeliver all documents, work papers and
other material of any other Party relating to the transactions
contemplated hereby, whether so obtained before or after the
execution of this Agreement, to the Party furnishing the same;
and
(ii) No Party hereto shall have any liability or further
obligation to any other Party to this Agreement except as stated
in this Section 6.2, as the case may be; provided, however, that
if such termination and/or abandonment is a result of the failure
of any condition set forth in Section 5.1 or 5.2 hereof or as a
result of the wilful conduct or bad faith of either Party, then
the other Party shall be entitled to recover from the Party whose
wilful conduct or bad faith resulted in such termination or
abandonment all out-of-pocket costs which the other Party has
incurred (including reasonable attorney's fees, accounting fees
and expenses).
7. Miscellaneous.
7.1 NOTICE. Any notice required or permitted hereunder shall be
in writing and shall be sufficiently given if personally delivered or mailed by
certified or registered mail, return receipt requested, addressed as follows:
If to Buyer: Barringer Laboratories, Inc.
15000 W. 6th Avenue, Suite 300
Golden, CO 80401
Attention: Chief Executive Officer
Copy to: Paul E. Rumler, Esq.
Rumler-Davies, P.C.
55 Madison Street, Suite 410
Denver, Colorado 80206
If to Seller; Barringer Technologies, Inc.
219 S. Street
New Providence, NJ 07974
Attention: President
(or to such other address as any party shall specify by written notice so
given), and shall be deemed to have been delivered as of the date so personally
delivered or mailed.
7.2 EXECUTION OF ADDITIONAL DOCUMENTS. The Parties hereto will
at any time, and from time to time after the Closing Date, upon request of the
other party, execute,
13
<PAGE>
acknowledge and deliver all such further acts, deeds, assignments, transfers,
conveyances, powers of attorney and assurances as may be required to carry out
the intent of this Agreement, and to transfer and vest title to any Shares being
transferred hereunder, and to protect the right, title and interest in and
enjoyment of all of the Shares sold, granted, assigned, transferred, delivered
and conveyed pursuant to this Agreement; provided, however, that this Agreement
shall be effective regardless of whether any such additional documents are
executed.
7.3 BINDING EFFECT: BENEFITS. This Agreement shall be binding
upon and shall inure to the benefit of the Parties hereto and their respective
heirs, successors, executors, administrators and assigns. Notwithstanding
anything contained in this Agreement to the contrary, nothing in this Agreement,
expressed or implied, is intended to confer on any person other than the Parties
hereto or their respective heirs, successors, executors, administrators and
assigns any rights, remedies, obligations or liabilities under or by reason of
this Agreement,
7.4 ENTIRE AGREEMENT. This Agreement, together with the other
documents contemplated hereby, constitute the final written expression of all of
the agreements between the Parties, and is a complete and exclusive statement of
those terms. It supersedes all understandings and negotiations concerning the
matters specified herein. Any representations, promises, warranties or
statements made by either party that differ in any way from the terms of this
written Agreement and the other documents contemplated hereby, shall be given no
force or effect. The Parties specifically represent, each to the other, that
there are no additional or supplemental agreements between them related in any
way to the matters herein contained unless specifically included or referred to
herein. No addition to or modification of any provision of this Agreement shall
be binding upon any party unless made in writing and signed by all Parties.
7.5 GOVERNING LAW. This Agreement and all matters and issues
collateral thereto shall be construed according to the laws of the State of
Colorado, except that issues governed by a state's corporate code, including
without limitation matters of corporate governance, shall be governed by the
laws of the Party's state of incorporation.
7.6 MEDIATION ARBITRATION. Notwithstanding anything to the
contrary herein provided, the Parties agree to submit disputes under this
Agreement which they are unable to resolve to mediation under the Commercial
Mediation Rules of the American Arbitration Association. Any dispute or
controversy arising out of or relating to this Agreement which is not resolved
through mediation shall be submitted and settled by arbitration under the Rules
of Conciliation and Arbitration of the International Chamber of Commerce (the
"ICC" then in effect. There shall be one arbitrator, and such arbitrator
shall be chosen by mutual agreement of the parties in accordance with ICC rules.
The arbitration proceedings shall take place at such location as the Parties
shall mutually agree upon, or if the Parties are unable to agree upon a
location, then Chicago, Illinois. The arbitrator shall apply the laws
14
<PAGE>
of the applicable state to all issues in dispute, in accordance with Section 7.5
hereof. The findings of the arbitrator shall be final and binding on the
parties, and may be enforced in any court of competent jurisdiction.
7.7 SURVIVAL. All of the terms, conditions, warranties and
representations contained in this Agreement shall survive, in accordance with
their terms, delivery by Buyer of the consideration to be given by it hereunder
and delivery by Seller of the consideration to be given by it hereunder, and
shall survive the execution hereof and the Closing hereunder for the period
provided herein.
7.8 COUNTERPARTS. This Agreement may be executed in any number
of counterparts, each of which shall be deemed an original but all of which
shall constitute one and the same instrument.
7.9 HEADINGS. Headings of the Articles and Sections of this
Agreement are for the convenience of the Parties only, and shall be given no
substantive or interpretive effect whatsoever.
7.10 WAIVERS. Either Buyer or Seller may, by written notice to
the other, (i) extend the time for the performance of any of the obligations or
other actions of the other under this Agreement; (ii) waive any inaccuracies in
the representations or warranties of the other contained in this Agreement or in
any document delivered pursuant to this Agreement; (iii) waive compliance with
any of the conditions or covenants of the other Party contained in this
Agreement; or (iv) waive performance of any of the obligations of the other
Party under this Agreement. Except as provided in the preceding sentence, no
action taken pursuant to this Agreement, including without limitation any
investigation by or on behalf of any Party, shall be deemed to constitute a
waiver, by the Party taking such action, of compliance with any representations,
warranties, covenants or agreements contained in this Agreement. The waiver by
any Party hereto of a breach of any provision hereunder shall not operate or be
construed as a waiver of any prior or subsequent breach of the same or any other
provision hereunder.
7.11 MERGER OF DOCUMENTS. This Agreement and all agreements and
documents contemplated hereby constitute one agreement. and are interdependent
upon each other in all respects.
7.12 SEVERABILITY. If for any reason whatsoever, any one or more
of the provisions of this Agreement shall be held or deemed to be inoperative,
unenforceable or invalid as applied to any particular case or in all cases, such
circumstances shall not have the effect of rendering such provision invalid in
any other one or of rendering any of the other provisions of this Agreement
inoperative, unenforceable or invalid.
15
<PAGE>
7.13 ASSIGNABILITY. Neither this Agreement nor any of the
Parties' rights hereunder shall be assignable by any party hereto without the
prior written consent of the other Parties hereto.
7.14 INTERPRETATION OF AGREEMENT. The Parties hereto each
represent and acknowledge that they have reviewed this Agreement with the
assistance of their respective counsel. The Parties further acknowledge that
each shall bear co-extensive and identical responsibility for the language of
this Agreement, and that any ambiguity which may exist or purportedly exist
therein shall be attributed equally to the Parties.
7.15. ATTORNEY'S FEES. If and Party shall commence any action
or proceeding against another Party in order to enforce the performances
hereof, or to recover damages as the result of the alleged breach of any of the
provisions hereof, the prevailing Party therein shall be entitled to recover all
reasonable costs incurred in connection therewith, including, but not limited
to, reasonable attorneys' fees.
IN WITNESS WHEREOF, the Parties have executed this Agreement and
caused the same to be duly delivered on their behalf on the day and year
hereinabove first set forth.
SELLER:
BARRINGER TECHNOLOGIES, INC.
By: /s/ Stanley S. Binder
------------------------------------
PRESIDENT
BUYER:
BARRINGER LABORATORIES, INC.
By: /s/ Robert H. Walker
------------------------------------
CEO
16
